Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease.
about
Aging, diabetes, and the public health system in the United StatesEstimated GFR reporting is not sufficient to allow detection of chronic kidney disease in an Italian regional hospital.Association of chronic kidney disease (CKD) and failure to monitor renal function with adverse outcomes in people with diabetes: a primary care cohort study.Development of next generation sequencing panel for UMOD and association with kidney disease.How to improve drug dosing for patients with renal impairment in primary care - a cluster-randomized controlled trial.Emerging drugs for chronic kidney disease.Routine screening for CKD should be done in asymptomatic adults... selectivelyPrevalence of chronic kidney disease across levels of glycemia among adults in Pudong New Area, Shanghai, China.A prospective clinical trial of specialist renal nursing in the primary care setting to prevent progression of chronic kidney: a quality improvement report.Metabolic syndrome and renal injuryBudget impact analysis of chronic kidney disease mass screening test in Japan.Development and validation of a self-assessment tool for albuminuria: results from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.The cardio-renal-anaemia syndrome predicts survival in peritoneally dialyzed patientsEstimated Glomerular Filtration Rate (eGFR): A Serum Creatinine-Based Test for the Detection of Chronic Kidney Disease and its Impact on Clinical Practice.Cost-effectiveness of chronic kidney disease mass screening test in Japan.Knowledge of physicians on chronic kidney disease and their attitudes towards referral, in two cities of Cameroon: a cross-sectional study.Screening tests for renal impairment in patients with type 2 diabetes: the what, when, and how.Novel effective drugs for diabetic kidney disease? or not?Comparison of equations for dosing of medications in renal impairment.Impact of metabolic syndrome on the incidence of chronic kidney disease: a Chinese cohort study.Endothelial Epas1 Deficiency Is Sufficient To Promote Parietal Epithelial Cell Activation and FSGS in Experimental Hypertension.Takotsubo Cardiomyopathy: Another Form of Cardiorenal Syndrome.Association of co-occurring serious mental illness with emergency hospitalization in people with chronic kidney disease.
P2860
Q26852929-40E35394-ACB1-4917-9282-A05316FC2E6EQ33499117-C1E828A4-0353-4415-85F8-9BACDDF4727DQ33588053-66C45F3C-BAA0-45F8-AC22-C6EBA7574420Q33793051-0A490DB9-85F5-45FA-B8BE-8B633004F899Q34407065-0FE4C077-11BB-4E40-87D7-5F5B41B307B3Q34420383-55C4F546-250C-4188-9C5B-0C285F8ECB70Q34455134-C4906433-E195-48E3-BAE6-C558F105FE6CQ34478646-5367A5B2-072F-4006-8550-0C9DAE79EEEEQ34677102-5BFC0687-337F-4F68-BC0E-54B96BF4FAEBQ34725449-B0AC7AAF-BF47-4002-9A71-AD2EE4EBFA19Q34737206-0D8C9D54-EF69-4553-B725-B6ABC5C1F8BDQ35129851-B3558B92-75AE-452A-AC2B-5F8FF9E5B01EQ35770743-D053C028-1273-4D1E-8464-47E1ED51749DQ35875301-CD736C52-05B0-45DD-BFDF-A81C0C27EF67Q35895018-6C462267-7E1C-416D-8087-F52EBC1B8CC0Q35896974-69D0A555-C7C6-43DD-916D-369F7A308C8EQ37835610-5DCE427F-FE0B-4DFE-A28F-C5E7A266FC70Q38265818-EFD918DC-BC75-4F87-B640-8D941A178B68Q38859441-C32CBA5A-0095-462C-8A0B-DC9FC9F7E69FQ39631387-66641013-B02B-4305-BBCF-CD3C8E1ED018Q47776165-0FAA727A-6E29-4FDE-818E-57676EC6CBD6Q48153266-C4AE2BCF-EB2E-4D05-AF53-76DD7F5E7FBCQ50652818-7942AC32-7253-4116-8899-96DC4E192332
P2860
Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Who should be targeted for CKD ...... n, and cardiovascular disease.
@en
Who should be targeted for CKD ...... n, and cardiovascular disease.
@nl
type
label
Who should be targeted for CKD ...... n, and cardiovascular disease.
@en
Who should be targeted for CKD ...... n, and cardiovascular disease.
@nl
prefLabel
Who should be targeted for CKD ...... n, and cardiovascular disease.
@en
Who should be targeted for CKD ...... n, and cardiovascular disease.
@nl
P2093
P1476
Who should be targeted for CKD ...... n, and cardiovascular disease.
@en
P2093
Allan J Collins
Changchun Wang
David T Gilbertson
Jiannong Liu
Joseph A Vassalotti
Robert N Foley
Shu-Cheng Chen
Thomas J Arneson
P356
10.1053/J.AJKD.2008.07.057
P433
P577
2009-03-01T00:00:00Z